ER
SYNH

Enlightenment Research’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Enlightenment Research’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,300
Closed -$51K – 724
2018
Q4 		$51K Buy
+1,300
New +$60.4K 0.06% 289

Other funds holding SYNH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Enlightenment Research's SYNH Position: Q1 2019 in Review

Enlightenment Research sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2019, closing a stake of 1,300 shares — an estimated $51K sold.

Enlightenment Research first reported a position in SYNH in Q4 2018 and held it in 1 quarter. The position peaked at $51K in Q4 2018. 262 funds tracked by Wall St. Rank hold SYNH as of Q1 2019.

  • Enlightenment Research reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2019 after selling out during the quarter.
  • Enlightenment Research sold 1,300 Syneos Health, Inc. Class A Common Stock shares in Q1 2019, an estimated $51K.
  • Enlightenment Research first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2018 and held it in 1 quarter.
  • Enlightenment Research's Syneos Health, Inc. Class A Common Stock position peaked at $51K in Q4 2018.
  • 262 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2019.

Based on Enlightenment Research's 13F filing for Q1 2019, filed 3 May 2019.